REGENXBIO Inc. (RGNX)
$7.26-6.56%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $375M
- Beta
- 0.93
- P/E (TTM)
- -1.92
- Short % float
- 21.62%
- Days to cover
- 6.0
- SI change
- +21.2%
- 1W
- -2.55%
- 1M
- -16.46%
- vs SPY 1W
- -2.41%
- vs SPY 1M
- -18.96%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RGNX?
- LOPJLB’s latest quantitative signal on REGENXBIO Inc. (RGNX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is RGNX in?
- REGENXBIO Inc. (RGNX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does REGENXBIO Inc. (RGNX) do?
- REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to rectify genetic deficiencies or to stimulate the body's own cells to produce therapeutic proteins or antibodies to combat diseases. Central to its therapeutic development is the proprietary NAV Te…